LS Investment Advisors LLC increased its position in shares of Masimo Corporation (NASDAQ:MASI) by 13.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,205 shares of the medical equipment provider’s stock after buying an additional 620 shares during the period. LS Investment Advisors LLC’s holdings in Masimo Corporation were worth $475,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. JPMorgan Chase & Co. increased its position in shares of Masimo Corporation by 11.2% in the first quarter. JPMorgan Chase & Co. now owns 455,338 shares of the medical equipment provider’s stock worth $42,466,000 after buying an additional 45,833 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Masimo Corporation by 36.9% in the first quarter. Geode Capital Management LLC now owns 645,254 shares of the medical equipment provider’s stock worth $60,175,000 after buying an additional 173,931 shares in the last quarter. Swiss National Bank increased its position in shares of Masimo Corporation by 0.9% in the first quarter. Swiss National Bank now owns 77,800 shares of the medical equipment provider’s stock worth $7,256,000 after buying an additional 700 shares in the last quarter. Norges Bank bought a new position in shares of Masimo Corporation during the fourth quarter worth about $26,532,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new position in shares of Masimo Corporation during the first quarter worth about $1,223,000. Institutional investors and hedge funds own 83.56% of the company’s stock.
Masimo Corporation (MASI) opened at 96.36 on Friday. Masimo Corporation has a 52 week low of $52.07 and a 52 week high of $104.71. The company’s 50-day moving average price is $93.22 and its 200 day moving average price is $88.78. The stock has a market capitalization of $4.93 billion, a P/E ratio of 16.36 and a beta of 0.80.
Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings data on Wednesday, May 3rd. The medical equipment provider reported $0.82 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.22. Masimo Corporation had a net margin of 44.86% and a return on equity of 24.19%. The company had revenue of $186.30 million during the quarter, compared to analysts’ expectations of $184.14 million. During the same period in the previous year, the company earned $0.53 EPS. The business’s quarterly revenue was up 8.8% compared to the same quarter last year. Equities research analysts expect that Masimo Corporation will post $2.66 EPS for the current fiscal year.
MASI has been the topic of a number of analyst reports. Zacks Investment Research downgraded Masimo Corporation from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 11th. Roth Capital lifted their price target on Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. BidaskClub upgraded Masimo Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Stifel Nicolaus initiated coverage on Masimo Corporation in a report on Monday, July 10th. They issued a “buy” rating and a $105.00 price target on the stock. Finally, Wedbush reiterated an “outperform” rating and issued a $112.00 price target on shares of Masimo Corporation in a report on Monday, May 22nd. Five investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $87.00.
In related news, Director Sanford Fitch sold 6,000 shares of the company’s stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $91.89, for a total transaction of $551,340.00. Following the completion of the sale, the director now directly owns 89,249 shares of the company’s stock, valued at approximately $8,201,090.61. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Anand Sampath sold 40,000 shares of the company’s stock in a transaction on Tuesday, July 11th. The stock was sold at an average price of $92.00, for a total transaction of $3,680,000.00. Following the sale, the chief operating officer now directly owns 20,000 shares of the company’s stock, valued at $1,840,000. The disclosure for this sale can be found here. Insiders have sold a total of 260,841 shares of company stock valued at $25,702,923 over the last three months. Corporate insiders own 16.60% of the company’s stock.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
